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• Dietary management of cardiovascular risk factors is seldom implemented in Switzerland 
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• Joint prevalence of several cardiovascular risk factors does not seem to increase the likelihood of dietary recommendations. 
• General practitioners should motivate their patients to adhere to a healthy diet rather than to avoid specific foods or nutrients  
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ABSTRACT 
Objective: to assess dietary management of cardiovascular risk factors (CVRFs) in the general 
population. 
Method: Cross-sectional study conducted between 2009 and 2012 on 4811 participants (2567 
women, 58±11 years) living in Lausanne, Switzerland. 
Results: Sixteen percent of participants diagnosed with overweight/obesity reported a slimming diet. 
Slimming diet was associated with diagnosis of hypertension: Odds ratio and (95% confidence 
interval): 0.61 (0.40-0.93); older age [0.84 (0.58-1.21), 0.79 (0.53-1.18) and 0.47 (0.27-0.81) for [50-
60[, [60-70[ and [70+ years, respectively]; female gender [1.84 (1.36-2.48)] and diagnosis of diabetes 
[2.16 (1.13-4.12)]. Only 8% of participants diagnosed with hypertension reported a low-salt diet. 
Low-salt diet was associated with antihypertensive drug treatment [2.17 (1.28-3.68)] and diagnosis 
of diabetes [2.72 (1.26-5.86)]. One-third of participants diagnosed with dyslipidemia reported a low-
fat diet. Low-fat diet was associated with female gender [1.47 (1.17–1.86)]; older age [1.29 (0.89-
1.87), 1.71 (1.18-2.48) and 2.01 (1.33-3.03) for [50-60[, [60-70[ and [70+ years, respectively]; 
hypolipidemic drug treatment [OR=1.68 (1.29-2.18)]; current smoking [0.70 (0.51-0.96)] and obesity 
[0.67 (0.45-1.00)]. Approximately half of participants diagnosed with diabetes reported an 
antidiabetic diet. Antidiabetic diet was associated with current smoking [0.44 (0.22-0.88)] and 
antidiabetic drug treatment [OR=3.26 (1.81-5.86)]. 
Conclusion: Dietary management of CVRFs is seldom implemented in Switzerland.  
 
Abstract word count: 199 
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INTRODUCTION 
Cardiovascular diseases (CVD) are the leading cause of death worldwide (2011). Adequate 
lifestyle including a healthy diet, avoidance of smoking, healthy body weight and regular physical 
activity has been shown to prevent the majority of CVD (2011).  
A healthy diet is paramount for the prevention and management of CVD (Hu and Willett, 
2002). Several randomized controlled trials have shown that appropriate dietary modifications 
positively affect blood pressure, lipid levels and overall CVD risk (Champagne, 2006; Dickinson et 
al., 2006; Hooper et al., 2012; Swain et al., 2008), a finding also observed for specific dietary 
patterns in the general population (Estruch et al., 2013). Conversely, observational epidemiologic 
studies have shown that consumption of saturated and trans fatty acids is associated with higher 
CVD rates (Erkkila et al., 2008). 
Even though accumulating evidence demonstrates the benefits of dietary management of 
cardiovascular risk factors (CVRF), little is known regarding if diagnosis of CVRFs is associated with 
healthy dietary implementation in Switzerland. Thus, our study aimed to assess the associations 
between diagnosis of CVRFs and presence of dietary intervention using self-reported as a proxy. 
PARTICIPANTS AND METHODS 
The Cohorte Lausannoise (CoLaus) study. 
The CoLaus study is a population-based study assessing the clinical, biological and genetic 
determinants of CVD in the city of Lausanne, Switzerland (Firmann et al., 2008). The study was 
approved by the Institutional Ethics Committee of the University of Lausanne and all participants 
provided written informed consent. The initial recruitment took place between June 2003 and 
May 2006 and enrolled 6,733 participants (3,544 women) aged 35-75 years; participation rate was 
41%. 
Follow-up was conducted between April 2009 and September 2012 and included all 
participants willing to be re-contacted. At follow-up, participants attended a single visit, which 
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included an interview, a physical exam, and blood and urine collections in the fasting state. Average 
follow-up time was 5.5 years. In this study, only data from the follow-up examination was 
considered as no information regarding dietary intake was available at baseline. 
Clinical and anthropometric data 
Educational level was categorized as low (primary), middle (apprenticeship or secondary 
school) and high (university). Smoking status was defined as never, former and current. Body weight 
and height were measured using standard procedures (Firmann et al., 2008) in the baseline and 
follow-up examinations. Body mass index (BMI) was defined as weight (kg)/height(m)2. Overweight 
was defined as 25≤BMI<30 kg/m2 and obesity as BMI≥30 kg/m2. Physical activity was assessed with 
a validated, self-administered quantitative physical activity frequency questionnaire developed in 
the Geneva general adult population (Bernstein et al., 1998). Sedentarity was defined as a total 
energy expenditure <10% in activities exceeding four times the basal metabolic rate. Information on 
sedentarity was missing for 17.5% of the sample. No data on income, stage of change or bariatric 
surgery was available. 
Awareness of overweight-obesity / hypertension / dyslipidemia or diabetes was considered 
if the participant responded positively to the questions “did a doctor tell you that you had excess 
weight / were hypertensive / had high cholesterol levels / were diabetic?” respectively. Participants 
were asked to bring all drugs (prescribed and over the counter) to the examination and drug 
treatment of hypertension, dyslipidemia or diabetes was assessed by identifying each individual 
drug. 
Dietary management of CVRF 
Participants were asked if they were currently on a diet, with five possible non-exclusive 
answers: to lose weight (slimming diet); low fat/against cholesterol; low sugar/against diabetes; low 
salt/against hypertension; other (with description). For analysis, each type of diet was 
considered as a yes/no variable. As dietary management of CVRFs can only be performed upon 
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diagnosis, analysis was restricted to participants who reported a previous diagnosis of 
overweight/obesity, hypertension, dyslipidemia or diabetes. No further information on the exact 
characteristics of the diet where asked; namely, no information was available whether the diet was 
self-prescribed or doctor-prescribed. 
Statistical analysis 
Statistical analyses were performed using Stata version 13.0 for windows (Stata Corp, College 
Station, TX, USA). Descriptive results were expressed as number of participants (percentage) or as 
average ± standard deviation. Bivariate analyses were performed using chi-square test for qualitative 
variables and Student’s t-test for quantitative variables. Multivariate analysis of the factors 
associated with the presence of a self-reported diet aimed at managing the condition (i.e. slimming, 
low salt or antidiabetic, respectively) was performed using logistic regression and the results were 
expressed as Odds ratio (OR) and 95% confidence interval (CI). Model goodness-of-fit, area under the 
receiver operating curve and the percentage of outcomes explained by the model were also 
provided. Sensitivity analyses were conducted with a further adjustment on sedentary status and 
after excluding participants aged over 70. Statistical significance was assessed for p<0.05. 
RESULTS 
Characteristics of the participants 
Of the initial 5064 participants, 138 (5%) were excluded because of missing data for any 
variable (except sedentary status) used in the analysis. The main characteristics of the remaining 
4811 participants overall and by gender are summarized in supplementary table 1. Men were 
younger, with higher levels of formal education, lived more frequently in couple, a higher prevalence 
of history of CVD, were more frequently overweight, obese and smokers and less frequently 
sedentary than women. Diagnosis of overweight/obesity, hypertension, dyslipidemia and diabetes 
was also higher among men (table 1). There were 70 (1.5%) underweight (BMI<18.5 kg/m2) 
participants (61 women, 9 men); none reported being on a slimming diet. 
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Dietary management of CVRF 
Only one sixth (16%) of participants diagnosed with overweight/obesity reported a slimming 
diet. On bivariate analysis, women, younger age and diagnosis of hypertension were positively 
associated with reporting a slimming diet (table 1). On multivariate analysis, women and diagnosis of 
overweight/obesity were positively associated, while older age or diagnosis of hypertension were 
negatively associated with reporting a slimming diet (table 2). 
Less than one tenth (8%) of participants with diagnosed hypertension reported a low salt 
diet. On bivariate analysis, personal history of CVD, diagnosis of diabetes and antihypertensive drug 
treatment were positively associated with reporting a salt diet (table 1). On multivariate analysis, 
personal history of CVD, diagnosis of hypertension or antihypertensive drug treatment were 
positively associated with reporting a low salt diet (table 2). 
One third (32%) of participants with diagnosed dyslipidemia reported a low fat diet, and less 
than half (47%) of participants with diagnosed diabetes reported an antidiabetic diet. On bivariate 
analysis, women, older age, lower education, personal history of CVD, and antihypertensive drug 
treatment were positively associated while smoking status was negatively associated with reporting 
a low fat diet (table 1). On multivariate analysis, women, older age, lower education, diagnosis of 
dyslipidemia or hypolipidemic drug treatment were positively associated with reporting a low fat diet 
(table 2). 
Less than half (47%) of participants with diagnosed diabetes reported an antidiabetic diet. 
On bivariate analysis, diagnosis of overweight/obesity, antihypertensive, hypolipidemic or 
antidiabetic drug treatment were positively associated while smoking status was negatively 
associated with reporting an antidiabetic diet (table 1). On multivariate analysis, older age, diagnosis 
of overweight/obesity, diagnosis of diabetes or antidiabetic drug treatment were associated with a 
higher likelihood of reporting an antidiabetic diet (Table 2). 
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Table 1. Bivariate analysis of clinical and socio-demographic factors associated with reported diet among participants diagnosed with obesity, hypertension, 
dyslipidemia and diabetes. 
 Obesity (N=1510) 
Slimming diet 
Hypertension (N=1657) 
Low salt diet 
Dyslipidemia (N=1568) 
Low fat diet 
Diabetes (N=379) 
Antidiabetic diet 
 No 
(N=1264) 
Yes 
(N=246) 
No 
(N=1531) 
Yes 
(N=126) 
No 
(N=1062) 
Yes 
(N=506) 
No 
(N=202) 
Yes 
(N=177) 
Gender         
Woman 604 (47.8) 154 (62.6) 697 (45.5) 59 (46.8) 449 (42.3) 273 (54.0) 67 (33.2) 55 (31.1) 
Man 660 (52.2) 92 (37.4) 834 (54.5) 67 (53.2) 613 (57.7) 233 (46.0) 135 (66.8) 122 (68.9) 
p-value <0.001 0.78 <0.001 0.66 
Age group (years)         
[40-50[ 309 (24.5) 73 (29.7) 220 (14.4) 12 (9.5) 220 (20.7) 57 (11.3) 18 (8.9) 18 (10.2) 
[50-60[ 389 (30.8) 78 (31.7) 414 (27.0) 27 (21.4) 330 (31.1) 124 (24.5) 49 (24.3) 39 (22.0) 
[60-70[ 367 (29.0) 72 (29.3) 536 (35.0) 51 (40.5) 324 (30.5) 190 (37.6) 81 (40.1) 70 (39.6) 
[70+[ 199 (15.7) 23 (9.4) 361 (23.6) 36 (28.6) 188 (17.7) 135 (26.7) 54 (26.7) 50 (28.3) 
p-value <0.05 0.14 <0.001 0.93 
Marital status         
Single 547 (43.3) 117 (47.6) 640 (41.8) 58 (46.0) 439 (41.3) 199 (39.3) 79 (39.1) 71 (40.1) 
Couple 717 (56.7) 129 (52.4) 891 (58.2) 68 (54.0) 623 (58.7) 307 (60.7) 123 (60.9) 106 (59.9) 
p-value 0.22 0.36 0.45 0.84 
Education         
 High 223 (17.6) 45 (18.3) 246 (16.1) 21 (16.7) 221 (20.8) 77 (15.2) 30 (14.9) 18 (10.2) 
 Middle 305 (24.1) 67 (27.2) 356 (23.3) 33 (26.2) 235 (22.1) 123 (24.3) 46 (22.8) 38 (21.5) 
 Low 736 (58.2) 134 (54.5) 929 (60.7) 72 (57.1) 606 (57.1) 306 (60.5) 126 (62.4) 121 (68.4) 
p-value 0.51 0.71 0.03 0.33 
History of CVD 1162 (91.9) 233 (94.7) 166 (10.8) 22 (17.5) 109 (10.3) 73 (14.4) 26 (12.9) 33 (18.6) 
p-value 0.13 0.03 0.02 0.12 
BMI categories         
Normal 89 (7.0) 17 (6.9) 406 (26.5) 35 (27.8) 352 (33.2) 176 (34.8) 37 (18.3) 26 (14.7) 
Overweight 572 (45.3) 110 (44.7) 679 (44.4) 51 (40.5) 468 (44.1) 218 (43.1) 82 (40.6) 72 (40.7) 
Obese 603 (47.7) 119 (48.4) 446 (29.1) 40 (31.8) 242 (22.8) 112 (22.1) 83 (41.1) 79 (44.6) 
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p-value 0.98 0.69 0.81 0.60 
Smoking categories         
Former 544 (43.0) 114 (46.3) 677 (44.2) 61 (48.4) 429 (40.4) 214 (42.3) 85 (42.1) 104 (58.8) 
Never 482 (38.1) 97 (39.4) 584 (38.2) 49 (38.9) 392 (36.9) 208 (41.1) 67 (33.2) 54 (30.5) 
Smoker 238 (18.8) 35 (14.2) 270 (17.6) 16 (12.7) 241 (22.7) 84 (16.6) 50 (24.8) 19 (10.7) 
p-value 0.22 0.35 0.02 <0.001 
Sedentarity         
No 345 (33.7) 70 (34) 438 (34.6) 46 (43) 333 (38.1) 168 (39) 36 (26.3) 36 (25.7) 
Yes 680 (66.3) 136 (66) 828 (65.4) 61 (57) 541 (61.9) 263 (61) 101 (73.7) 104 (74.3) 
p-value 0.93 0.08 0.76 0.92 
Diagnosed overweight/obesity - - 719 (47.0) 60 (47.6) 438 (41.2) 215 (42.5) 120 (59.4) 124 (70.1) 
p-value NA 0.89 0.64 0.03 
Diagnosed hypertension 671 (53.1) 108 (43.9) - - 489 (46.1) 253 (50.0) 121 (59.9) 119 (67.2) 
p-value 0.008 NA 0.14 0.14 
Diagnosed dyslipidemia 560 (44.3) 93 (37.8) 684 (44.7) 58 (46.0) - - 118 (58.4) 116 (65.5) 
p-value 0.06 0.77 NA 0.16 
Diagnosed diabetes 207 (16.4) 37 (15.0) 214 (14.0) 26 (20.6) 158 (14.9) 76 (15.0) - - 
p-value 0.60 0.04 0.94 NA 
Treated hypertension 541 (42.8) 95 (38.6) 1068 (69.8) 106 (84.1) 411 (38.7) 231 (45.7) 116 (57.4) 119 (67.2) 
p-value 0.22 0.001 0.009 0.05 
Treated dyslipidemia 372 (29.4) 64 (26.0) 510 (33.3) 47 (37.3) 498 (46.9) 312 (61.7) 90 (44.6) 109 (61.6) 
p-value 0.28 0.36 <0.001 0.001 
Treated diabetes 169 (13.4) 23 (9.4) 170 (11.1) 17 (13.5) 118 (11.1) 56 (11.1) 122 (60.4) 149 (84.2) 
p-value 0.08 0.42 0.98 <0.001 
Personal physician 1184 (93.7) 232 (94.3) 1469 (96.0) 122 (96.8) 1010 (95.1) 490 (96.8) 193 (95.5) 169 (95.5) 
p-value 0.71 0.63 0.12 0.98  
Results are expressed as number of participants and (column percentage). BMI, body mass index; CVD, cardiovascular disease; NA, not assessable. Between-
group comparisons performed using chi-square. 
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Table 2: multivariate analysis of the clinical and socio-demographic factors associated with reported diet, among participants diagnosed with obesity, 
hypertension, dyslipidemia or diabetes 
 Obesity 
(slimming diet) 
Hypertension 
(low salt diet) 
Dyslipidemia 
(low fat diet) 
Diabetes 
(antidiabetic diet) 
Gender (woman vs. man) 1.84 (1.36 - 2.48) 1.09 (0.73 - 1.61) 1.47 (1.17 - 1.86) 1.06 (0.65 - 1.74) 
Age group      
[40-50[ 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 
[50-60[ 0.84 (0.58 - 1.21) 1.03 (0.50 - 2.10) 1.29 (0.89 - 1.87) 0.67 (0.27 - 1.62) 
[60-70[ 0.79 (0.53 - 1.18) 1.27 (0.64 - 2.51) 1.71 (1.18 - 2.48) 0.48 (0.20 - 1.14) 
[70+[ 0.47 (0.27 - 0.81) 1.23 (0.59 - 2.53) 2.01 (1.33 - 3.03) 0.42 (0.17 - 1.07) 
p-value for trend 0.008 0.47 <0.001 0.05 
Education     
 High 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 
 Middle 1.08 (0.71 - 1.66) 1.00 (0.56 - 1.79) 1.41 (0.99 - 2.00) 1.29 (0.59 - 2.84) 
 Low 0.87 (0.59 - 1.28) 0.77 (0.45 - 1.30) 1.27 (0.93 - 1.74) 1.47 (0.73 - 2.97) 
p-value for trend 0.49 0.33 0.13 0.28 
History of CVD (Yes vs. No) 0.78 (0.41 - 1.49) 1.59 (0.93 - 2.75) 1.23 (0.86 - 1.75) 1.27 (0.67 - 2.40) 
BMI categories (%)     
Normal - 1 (ref.) 1 (ref.) 1 (ref.) 
Overweight - 0.82 (0.50 - 1.35) 0.81 (0.61 - 1.08) 0.79 (0.39 - 1.61) 
Obese - 0.90 (0.47 - 1.73) 0.67 (0.45 - 1.00) 0.63 (0.27 - 1.45) 
p-value for trend - 0.75 0.05 0.28 
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Smoking categories (%)     
Never 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 
Former 1.20 (0.88 - 1.63) 1.00 (0.67 - 1.51) 0.94 (0.73 - 1.20) 1.43 (0.87 - 2.35) 
Smoker 0.73 (0.48 - 1.12) 0.70 (0.39 - 1.27) 0.70 (0.51 - 0.96) 0.44 (0.22 - 0.88) 
p-value for trend 0.15 0.24 0.03 0.02 
Diagnosed overweight/obesity (Yes vs. No) - 0.99 (0.60 - 1.63) 1.26 (0.94 - 1.68) 1.38 (0.75 - 2.51) 
Diagnosed hypertension (Yes vs. No) 0.61 (0.40 - 0.93) - 0.94 (0.69 - 1.29) 1.18 (0.61 - 2.29) 
Diagnosed dyslipidemia (Yes vs. No) 0.79 (0.54 - 1.14) 0.93 (0.56 - 1.54) - 1.01 (0.56 - 1.81) 
Diagnosed diabetes (Yes vs. No) 2.16 (1.13 - 4.12) 2.72 (1.26 - 5.86) 1.13 (0.65 - 1.98) - 
Treated hypertension (Yes vs. No) 1.46 (0.93 - 2.29) 2.17 (1.28 - 3.68) 0.96 (0.68 - 1.36) 0.84 (0.41 - 1.72) 
Treated dyslipidemia (Yes vs. No) 1.31 (0.84 - 2.05) 0.93 (0.53 - 1.63) 1.68 (1.29 - 2.18) 1.43 (0.78 - 2.64) 
Treated diabetes (Yes vs. No) 0.39 (0.18 - 0.85) 0.42 (0.17 - 1.03) 0.69 (0.36 - 1.30) 3.26 (1.81 - 5.86) 
Physician (Yes vs. No) 1.19 (0.65 - 2.18) 1.00 (0.35 - 2.85) 1.13 (0.62 - 2.04) 0.89 (0.29 - 2.73) 
Model characteristics     
Goodness-of-fit (p-value) 0.42 0.007 0.44 0.25 
Area under the ROC curve 0.640 0.633 0.640 0.701 
Proportion of outcomes explained (%) 83.7 92.4 67.6 63.9 
 
Results are expressed as Odds-ratio and (95% confidence interval). BMI, body mass index; CVD, cardiovascular disease. Analysis by logistic regression 
adjusting for all variables included in the model. Goodness-of-fit was assessed by Hosmer-Lemeshow test and results are provided as p-value; a p-value 
>0.05 indicates adequate fit. 
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Similar findings were obtained after further adjusting for sedentary status (supplementary 
table 2) or after excluding participants aged over 70 (supplementary table 2). 
DISCUSSION 
To our knowledge, this is the first study to assess adherence to dietary recommendation for 
CVRFs in Switzerland. Our results indicate that, in this Swiss population-based study, diagnosis of 
CVRFs is seldom associated with dietary measures. 
Over three-quarters of all CVD mortality could be prevented by lifestyle-induced reduction of 
CVRFs (2011), and European guidelines state that dietary modifications should form the basis for CVD 
prevention (Perk et al., 2012). Still, in this study, a low prevalence of dietary management of CVRFs 
was noted. Likely explanations include the lack of 1) nutritional knowledge of Swiss doctors, as it has 
been reported in the UK (Barratt, 2001); 2) adherence to dietary recommendations of patients 
(Vernay et al., 2012), or 3) reimbursement of dietician’s consultations . Thus, efforts should be made 
to implement dietary management in patients with CVRFs, either by increasing dietary knowledge of 
doctors, by increasing patients’ adherence or by facilitating access to dieticians or nutritionists. 
Obesity 
Obesity is associated with an increased mortality from CVD (Lavie et al., 2009). Weight 
reduction leads to a decrease in hypertension (Siebenhofer et al., 2011) and diabetes (Lindstrom et 
al., 2013). In this study, only one sixth of the participants diagnosed with overweight/obesity 
reported being on a slimming diet. This value is considerably lower than in the US (Post et al., 2011) 
but comparable to a Portuguese study (Marques-Vidal et al., 2011) and slightly better than a Spanish 
study (10%) (Rodriguez-Martin et al., 2009). Women and younger participants were more likely to be 
on a slimming diet, a finding also reported elsewhere (Rodriguez-Martin et al., 2009). Possible 
explanations include the social importance and the media pressure for an adequate body image 
among young people, namely women (Cuadrado et al., 2000) and the increasing presence of 
slimming advices in women’s magazines (Barker et al., 2013). Treatment of diabetes was negatively 
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associated, while diagnosis of diabetes was positively associated with a slimming diet. One possible 
explanation is the belief by patients that antidiabetic treatment makes dietary management 
(including weight loss) unnecessary, as suggested by their higher ranking of medication relative to 
diet and exercise (Broadbent et al., 2011) 
Hypertension 
Dietary management is one of the main treatment strategies for hypertension (Mancia et al., 
2014). Sodium reduction associated with other dietary recommendations has been shown to be 
effective in reducing blood pressure levels (Bray et al., 2004; He et al., 2013; Sacks et al., 2001), 
although no effect of sodium reduction on cardiovascular or overall mortality has been found 
(DiNicolantonio et al., 2013; Taylor et al., 2011). In this study, only a small number of participants 
diagnosed with hypertension reported being on a low salt diet, a value lower than reported in other 
studies (Hu et al., 2013; Warren-Findlow and Seymour, 2011). A possible explanation is the difficulty 
in implementing low salt diets (He and MacGregor, 2010). Finally, no sociodemographic or clinical 
variable was significantly associated with being on a low salt diet, most probably because of the small 
sample size, which would have reduced statistical power. Nevertheless, our results show that Swiss 
doctors should be sensitized regarding prescription of low salt diet to their hypertensive patients. 
Lipids 
Dietary factors have been shown to influence atherogenesis directly or through effects on 
lipid levels (Mancia et al., 2014), and guidelines regarding dietary management of dyslipidemia have 
been issued (European Association for Cardiovascular et al., 2011). In this study, one third of 
participants diagnosed with dyslipidemia reported being on a low-fat diet, a value higher than 
reported for Poland (20%) (Waskiewicz et al., 2008) or in the US, where only 11.7% of visits to 
primary care physicians included any type of counselling for diet or nutrition (Kulick et al., 2013). On 
multivariate analysis, women and elderly participants were more likely to report being on a low fat 
diet. Possible explanations include a better health management by women, although other 
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explanations such as a desire to lose weight (low fat diets are usually associated with slimming) 
cannot be ruled out. The higher adoption of a low fat diet by elderly people could also be due to the 
fact that they retained their dietary habits. As fat content of the Swiss diet increased from 33.5% in 
1961 to 40.3% of total caloric intake in 2007 (Guerra et al., 2012), it is possible that older participants 
might have fewer difficulties in implementing low-fat diets. 
Diabetes 
Healthy dietary management (including weight loss) successfully prevents the development 
of diabetes (Lindstrom et al., 2013), and most guidelines emphasize dietary intervention for the 
management of diabetes (Authors/Task Force et al., 2013; Bantle et al., 2006). Still, only half of the 
participants diagnosed with diabetes reported being on an antidiabetic diet, a value also reported 
elsewhere (Davison et al., 2014; Munoz-Pareja et al., 2012; Peytremann-Bridevaux et al., 2013). 
Possible explanations include a lower adherence to diet because of reduction in the patient’s quality 
of life (Puder et al., 2005), limited access to dieticians (Peytremann-Bridevaux et al., 2013) or a 
reduced knowledge of doctors regarding dietary management of diabetes. Still, our results question 
the current dietary management of diabetes in the Swiss population. 
Implication for clinical practice 
Our results strongly suggest that dietary management of CVRFs is neglected in the general 
population. Further, presence of other CVRFs (with the exception of diabetes) did not increase the 
likelihood of reporting a diet, also suggesting that diet implementation is directed towards a single 
CVRF. Still, dietary management of CVRFs should promote an overall healthy diet rather than 
focusing on single CVRFs. Indeed, the joint effects of energy and nutrient changes provide more 
health benefits than intervention on an individual dietary component (Champagne, 2006; Riegel et 
al., 2012). Thus, general practitioners should motivate their patients to adhere to a healthy diet 
rather than to avoid specific foods or nutrients. 
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Study limitations 
This study has several limitations worth acknowledging for. Firstly, no information was 
available whether the diet was self-prescribed or doctor-prescribed. This self-prescription applies 
mostly to slimming diets, although other types of diet can also be impacted. Hence, it is likely that 
the actual prescription rates of dietary management by Swiss doctors are lower than reported. 
Secondly, it was not possible to confirm (i.e. via a 24h urine collection) if participants reporting a low 
salt diet were actually compliant with the dietary recommendations. Still, this would decrease even 
further the very low prevalence of hypertensive participants on a low salt diet, as it has been 
demonstrated that only a limited number of patients succeed in reducing their salt consumption to 
the desired levels (Korhonen et al., 1999). Thirdly, it is possible that participants who did not report 
being on a modified diet already had a healthy dietary intake, so no specific changes were deemed 
necessary. The assessment of energy and nutrient intake will provide more information on the 
adequacy of diets consumed by participants with CVRFs. Fourthly, the cross-sectional design of the 
study is a limitation because it is not possible to know if it is the diagnosis that makes the participants 
modify their diet or if they do it by themselves. The ongoing collection of new data in the same 
cohort will allow such a study in the forthcoming years. Finally, no information was collected 
regarding previous adherence to dietary recommendations. Hence, it is possible that a sizable 
number of participants diagnosed with CVRFs actually received dietary recommendations but failed 
to implement them. Still, as dietary management of CVRFs should be a lifelong process, or results 
suggest that implementation of a healthy diet among participants with CVRFs should be improved. 
Conclusion 
Diagnosis of CVRF is seldom associated with self-reported diet. Dietary prevention of CVRFs 
appears to complement drug treatment rather than to be an essential part of CVRF management. 
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Figure 1 
  
  
 
1 
 
Supplementary table 1: Clinical and socio-demographic factors associated with reported diet among participants diagnosed with obesity, 
hypertension, dyslipidemia and diabetes. 
 Obesity (N=1510) 
Slimming diet 
Hypertension (N=1657) 
Low salt diet 
Dyslipidemia (N=1568) 
Low fat diet 
Diabetes (N=379) 
Antidiabetic diet 
 No 
(N=1264) 
Yes 
(N=246) 
No 
(N=1531) 
Yes 
(N=126) 
No 
(N=1062) 
Yes 
(N=506) 
No 
(N=202) 
Yes 
(N=177) 
Gender         
Woman 604 (47.8) 154 (62.6) 697 (45.5) 59 (46.8) 449 (42.3) 273 (54.0) 67 (33.2) 55 (31.1) 
Man 660 (52.2) 92 (37.4) 834 (54.5) 67 (53.2) 613 (57.7) 233 (46.0) 135 (66.8) 122 (68.9) 
p-value <0.001 0.78 <0.001 0.66 
Age group (years)         
[40-50[ 309 (24.5) 73 (29.7) 220 (14.4) 12 (9.5) 220 (20.7) 57 (11.3) 18 (8.9) 18 (10.2) 
[50-60[ 389 (30.8) 78 (31.7) 414 (27.0) 27 (21.4) 330 (31.1) 124 (24.5) 49 (24.3) 39 (22.0) 
[60-70[ 367 (29.0) 72 (29.3) 536 (35.0) 51 (40.5) 324 (30.5) 190 (37.6) 81 (40.1) 70 (39.6) 
[70+[ 199 (15.7) 23 (9.4) 361 (23.6) 36 (28.6) 188 (17.7) 135 (26.7) 54 (26.7) 50 (28.3) 
p-value <0.05 0.14 <0.001 0.93 
Marital status         
Single 547 (43.3) 117 (47.6) 640 (41.8) 58 (46.0) 439 (41.3) 199 (39.3) 79 (39.1) 71 (40.1) 
Couple 717 (56.7) 129 (52.4) 891 (58.2) 68 (54.0) 623 (58.7) 307 (60.7) 123 (60.9) 106 (59.9) 
p-value 0.22 0.36 0.45 0.84 
Education         
   High 223 (17.6) 45 (18.3) 246 (16.1) 21 (16.7) 221 (20.8) 77 (15.2) 30 (14.9) 18 (10.2) 
   Middle 305 (24.1) 67 (27.2) 356 (23.3) 33 (26.2) 235 (22.1) 123 (24.3) 46 (22.8) 38 (21.5) 
   Low 736 (58.2) 134 (54.5) 929 (60.7) 72 (57.1) 606 (57.1) 306 (60.5) 126 (62.4) 121 (68.4) 
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p-value 0.51 0.71 0.03 0.33 
History of CVD 1162 (91.9) 233 (94.7) 166 (10.8) 22 (17.5) 109 (10.3) 73 (14.4) 26 (12.9) 33 (18.6) 
p-value 0.13 0.03 0.02 0.12 
BMI categories         
Normal 89 (7.0) 17 (6.9) 406 (26.5) 35 (27.8) 352 (33.2) 176 (34.8) 37 (18.3) 26 (14.7) 
Overweight 572 (45.3) 110 (44.7) 679 (44.4) 51 (40.5) 468 (44.1) 218 (43.1) 82 (40.6) 72 (40.7) 
Obese 603 (47.7) 119 (48.4) 446 (29.1) 40 (31.8) 242 (22.8) 112 (22.1) 83 (41.1) 79 (44.6) 
p-value 0.98 0.69 0.81 0.60 
Smoking categories         
Former 544 (43.0) 114 (46.3) 677 (44.2) 61 (48.4) 429 (40.4) 214 (42.3) 85 (42.1) 104 (58.8) 
Never 482 (38.1) 97 (39.4) 584 (38.2) 49 (38.9) 392 (36.9) 208 (41.1) 67 (33.2) 54 (30.5) 
Smoker 238 (18.8) 35 (14.2) 270 (17.6) 16 (12.7) 241 (22.7) 84 (16.6) 50 (24.8) 19 (10.7) 
p-value 0.22 0.35 0.02 <0.001 
Diagnosed overweight/obesity - - 719 (47.0) 60 (47.6) 438 (41.2) 215 (42.5) 120 (59.4) 124 (70.1) 
p-value NA 0.89 0.64 0.03 
Diagnosed hypertension 671 (53.1) 108 (43.9) - - 489 (46.1) 253 (50.0) 121 (59.9) 119 (67.2) 
p-value 0.008 NA 0.14 0.14 
Diagnosed dyslipidemia 560 (44.3) 93 (37.8) 684 (44.7) 58 (46.0) - - 118 (58.4) 116 (65.5) 
p-value 0.06 0.77 NA 0.16 
Diagnosed diabetes 207 (16.4) 37 (15.0) 214 (14.0) 26 (20.6) 158 (14.9) 76 (15.0) - - 
p-value 0.60 0.04 0.94 NA 
Treated hypertension 541 (42.8) 95 (38.6) 1068 (69.8) 106 (84.1) 411 (38.7) 231 (45.7) 116 (57.4) 119 (67.2) 
p-value 0.22 0.001 0.009 0.05 
Treated dyslipidemia 372 (29.4) 64 (26.0) 510 (33.3) 47 (37.3) 498 (46.9) 312 (61.7) 90 (44.6) 109 (61.6) 
p-value 0.28 0.36 <0.001 0.001 
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Treated diabetes 169 (13.4) 23 (9.4) 170 (11.1) 17 (13.5) 118 (11.1) 56 (11.1) 122 (60.4) 149 (84.2) 
p-value 0.08 0.42 0.98 <0.001 
Personal physician 1184 (93.7) 232 (94.3) 1469 (96.0) 122 (96.8) 1010 (95.1) 490 (96.8) 193 (95.5) 169 (95.5) 
p-value 0.71 0.63 0.12 0.98 
 
Results are expressed as number of participants and (column percentage). BMI, body mass index; CVD, cardiovascular disease; NA, not 
assessable. Between-group comparisons performed using chi-square. 
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Supplementary table 2: multivariate analysis of the clinical and socio-demographic factors associated with reported diet, among participants 
diagnosed with obesity, hypertension, dyslipidemia or diabetes 
 Obesity 
(slimming diet) 
Hypertension 
(low salt diet) 
Dyslipidemia 
(low fat diet) 
Diabetes 
(antidiabetic diet) 
Gender (woman vs. man) 1.84 (1.36 - 2.48) *** 1.09 (0.73 - 1.61) 1.47 (1.17 - 1.86) *** 1.06 (0.65 - 1.74) 
Age group      
[40-50[ 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 
[50-60[ 0.84 (0.58 - 1.21) 1.03 (0.50 - 2.10) 1.29 (0.89 - 1.87) 0.67 (0.27 - 1.62) 
[60-70[ 0.79 (0.53 - 1.18) 1.27 (0.64 - 2.51) 1.71 (1.18 - 2.48) ** 0.48 (0.20 - 1.14) 
[70+[ 0.47 (0.27 - 0.81) ** 1.23 (0.59 - 2.53) 2.01 (1.33 - 3.03) *** 0.42 (0.17 - 1.07) 
p-value for trend 0.008 0.47 <0.001 0.05 
Education     
   High 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 
   Middle 1.08 (0.71 - 1.66) 1.00 (0.56 - 1.79) 1.41 (0.99 - 2.00) 1.29 (0.59 - 2.84) 
   Low 0.87 (0.59 - 1.28) 0.77 (0.45 - 1.30) 1.27 (0.93 - 1.74) 1.47 (0.73 - 2.97) 
p-value for trend 0.49 0.33 0.13 0.28 
History of CVD (Yes vs. No) 0.78 (0.41 - 1.49) 1.59 (0.93 - 2.75) 1.23 (0.86 - 1.75) 1.27 (0.67 - 2.40) 
BMI categories (%)     
Normal - 1 (ref.) 1 (ref.) 1 (ref.) 
Overweight - 0.82 (0.50 - 1.35) 0.81 (0.61 - 1.08) 0.79 (0.39 - 1.61) 
Obese - 0.90 (0.47 - 1.73) 0.67 (0.45 - 1.00) * 0.63 (0.27 - 1.45) 
p-value for trend - 0.75 0.05 0.28 
Smoking categories (%)     
5 
 
Never 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 
Former 1.20 (0.88 - 1.63) 1.00 (0.67 - 1.51) 0.94 (0.73 - 1.20) 1.43 (0.87 - 2.35) 
Smoker 0.73 (0.48 - 1.12) 0.70 (0.39 - 1.27) 0.70 (0.51 - 0.96) * 0.44 (0.22 - 0.88) * 
p-value for trend 0.15 0.24 0.03 0.02 
Diagnosed overweight/obesity (Yes vs. No) - 0.99 (0.60 - 1.63) 1.26 (0.94 - 1.68) 1.38 (0.75 - 2.51) 
Diagnosed hypertension (Yes vs. No) 0.61 (0.40 - 0.93) * - 0.94 (0.69 - 1.29) 1.18 (0.61 - 2.29) 
Diagnosed dyslipidemia (Yes vs. No) 0.79 (0.54 - 1.14) 0.93 (0.56 - 1.54) - 1.01 (0.56 - 1.81) 
Diagnosed diabetes (Yes vs. No) 2.16 (1.13 - 4.12) * 2.72 (1.26 - 5.86) * 1.13 (0.65 - 1.98) - 
Treated hypertension (Yes vs. No) 1.46 (0.93 - 2.29) 2.17 (1.28 - 3.68) ** 0.96 (0.68 - 1.36) 0.84 (0.41 - 1.72) 
Treated dyslipidemia (Yes vs. No) 1.31 (0.84 - 2.05) 0.93 (0.53 - 1.63) 1.68 (1.29 - 2.18) *** 1.43 (0.78 - 2.64) 
Treated diabetes (Yes vs. No) 0.39 (0.18 - 0.85) * 0.42 (0.17 - 1.03) 0.69 (0.36 - 1.30) 3.26 (1.81 - 5.86) *** 
Physician (Yes vs. No) 1.19 (0.65 - 2.18) 1.00 (0.35 - 2.85) 1.13 (0.62 - 2.04) 0.89 (0.29 - 2.73) 
 
Results are expressed as Odds-ratio and (95% confidence interval). BMI, body mass index; CVD, cardiovascular disease. Analysis by logistic 
regression adjusting for all variables included in the model: *, p<0.05; **, p<0.01; ***, p<0.001. 
 
 
